Method and apparatus for electrically stimulating the nervous system to improve ventricular dysfunction, heart failure, and other cardiac conditions

• US 8,417,334 B2
• Filed: 10/26/2001
• Issued: 04/09/2013
• Est. Priority Date: 10/26/2000
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Hill, Michael R. S., King, Gary W., Mullen, Thomas J., Zhou, Xiaohong
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): OROPEZA, FRANCES P
• Application Number:
  US10/039,307
• Publication Number:
  US 20020107553A1
• Time in Patent Office: 4,183 Days
• Field of Search: 600/373, 600/374, 600/377, 600/381, 600/382, 600/384, 600/509, 607 4- 7, 607 9- 11, 607/17, 607/119, 607/120, 607/122
• US Class Current: 607/9
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy

Abstract

A method and apparatus are used to provide therapy to a patient experiencing ventricular dysfunction or heart failure. At least one electrode is located in a region associated with nervous tissue, such as nerve bundles T1-T4, in a patient'"'"'s body. Electrical stimulation is applied to the at least one electrode to improve the cardiac efficiency of the patient'"'"'s heart. One or more predetermined physiologic parameters of the patient are monitored, and the electrical stimulation is adjusted based on the one or more predetermined physiologic parameters.

Claims

1. An apparatus for treating a patient to improve cardiac performance and efficiency of the patient'"'"'s heart, the apparatus comprising:

at least one electrode adapted to be located in a region associated with nervous tissue in a patient;

means for monitoring one or more physiologic parameters of the patient;

means for automatically applying electrical stimulation via the at least one electrode to improve balance of a neuro-endocrinological system of the patient in response to the one or more physiologic parameters of the patient; and

means for delivering a pacing therapy to the patient'"'"'s heart of a type that improves cardiac output, wherein said pacing therapy consists of a cardiac resynchronization therapy; and

means for adjusting the electrical stimulation applied during delivery of the pacing therapy responsive to the one or more physiological parameters of the patient as monitored during delivery of the pacing therapy.

2. The apparatus of claim 1, wherein the at least one electrode further comprises at least one implanted electrode adapted to be located adjacent a patient'"'"'s spine.

3. The apparatus of claim 1, wherein the at least one electrode is adapted to be located external to and in direct contact with a portion of skin of the patient'"'"'s.

4. The apparatus of claim 1, wherein the at least one electrode is adapted to be located in a subcutaneous space of the patient'"'"'s body.

5. The apparatus of claim 1 wherein delivery of the pacing therapy comprises altering a previously delivered pacing therapy in conjunction with applying the electrical stimulation.

6. The apparatus of claim 1 wherein delivery of the pacing therapy comprises initiating delivery of the pacing therapy in conjunction with applying the electrical stimulation.

7. The apparatus of claim 1 wherein the monitoring means comprises a pressure sensor.

8. The apparatus of claim 1 wherein the monitoring means comprises a pressure sensor adapted for a cardiac location.

9. The apparatus of claim 8 wherein the monitoring means comprises means for determining the patient'"'"'s diastolic pressure.

10. The apparatus of claim 1 wherein the monitoring means comprises means for sensing heart rate.

11. The apparatus of claim 10 wherein the monitoring means comprises means for sensing heart rate variability.